Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation-Reference-Cited by-同舟云学术

Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation

Published:2023-12 Issue:12 Volume:41 Page:2066-2082.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Chen Chia-Chun^ORCID,Tran Wendy,Song Kai,Sugimoto Tyler,Obusan Matthew B.,Wang Liang,Sheu Katherine M.,Cheng Donghui,Ta Lisa,Varuzhanyan Grigor,Huang Arthur,Xu Runzhe,Zeng Yuanhong,Borujerdpur Amirreza,Bayley Nicholas A.,Noguchi Miyako,Mao Zhiyuan,Morrissey Colm,Corey Eva,Nelson Peter S.,Zhao Yue,Huang Jiaoti,Park Jung Wook,Witte Owen N.^ORCID,Graeber Thomas G.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference95 articles.

1. Small cell carcinoma of the prostate;Nadal;Nat. Rev. Urol.,2014

2. Small cell lung cancer: will recent progress lead to improved outcomes?;Pietanza;Clin. Cancer Res.,2015

3. Clinical and Biological Features of Neuroendocrine Prostate Cancer;Yamada;Curr. Oncol. Rep.,2021

4. Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies;Balanis;Cancer Cell,2019

5. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer;Cejas;Nat. Commun.,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

2. Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines;2024-08-30

3. A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer;2024-08-19

4. Mechanisms governing lineage plasticity and metabolic reprogramming in cancer;Trends in Cancer;2024-08

5. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies;Cancer Cell;2024-08